Genetic Testing

Genetic Signatures Predict Outcomes, Advance Personalized Treatment

by Erin McNemar, MPA

Baylor College of Medicine researchers have discovered a genetic signature that can predict poor patient outcomes in estrogen-receptor positive (ER+) breast cancer, potentially leading to personalized...

Advancing Personalized Treatment For Throat Cancer Patients

by Erin McNemar, MPA

University of California researchers are studying how to advance personalized treatment for patients with HPV-associated oropharyngeal cancer. The research led by Robert Chin, MD, PhD, a radiation...

Machine Learning Predicts Cancer Treatment Response

by Erin McNemar, MPA

The Georgia Institute of Technology and Ovarian Cancer Institute researchers are using machine learning algorithms to predict how patients will respond to cancer-fighting drugs. Advances in machine...

Predictive Analytics Finds Genetic Biomarkers Tied to Severe COVID-19

by Erin McNemar, MPA

Using predictive analytics, the University of Colorado School of Medicine and UCHealth University of Colorado Hospital scientists have found specific genetic biomarkers that show who is infected with...

NIH Study Links Rare Disease to Higher Healthcare Costs

by Erin McNemar, MPA

In a retrospective study led by the National Institutes of Health’s National Center for Advancing Translation Sciences (NCATS), researchers provide evidence that individuals with rare diseases...

Genomics Study Reveals Variants Behind Inherited Retinal Dystrophies

by Erin McNemar, MPA

University of California San Diego and Shiley Eye Institute at UC San Diego Health scientists analyzed how inherited retinal dystrophies (IRDs) impact diverse populations of people. Through the...

Using Artificial Intelligence to Diagnose Rare Pediatric Disorders

by Erin McNemar, MPA

According to a collaborative research study from the University of Utah Health, Fabric Genomics, and Rady Children’s Hospital, artificial intelligence-based technology can rapidly diagnose rare...

Improving Precision Medicine Accessibility Among Admixed Populations

by Erin McNemar, MPA

University of California San Diego School of Medicine researchers have been awarded $11.7 million to launch the Genetic & Social Determinants of Health: Center for Admixture Science and Technology...

New Alzheimer’s Treatment Advances Precision Medicine

by Erin McNemar, MPA

In a study by the National Institute on Aging (NIA), researchers have found that a commonly available oral diuretic pill approved by the United States Food and Drug Administration is a potential...

Unvaccinated Pregnant Women Face Population Health Impacts

by Erin McNemar, MPA

According to UT Southwestern Medical Center researchers, unvaccinated pregnant women are increasingly hospitalized due to COVID-19, impacting population health. The study, which analyzed more than...

Genetic Mutations Key to Precision Medicine, Cancer Prevention

by Erin McNemar, MPA

A recent study indicated that genetic mutations in blood cells caused by smoking and aging-related changed could be risk factors for a rare type of blood cancer that impacts immune cells. The findings...

Blood Enzyme Activity Predicts Chronic Disease Progression

by Erin McNemar, MPA

SWOG Cancer Research Network researchers have discovered that blood enzyme activity levels could determine the chronic disease progression of breast cancer.  The study indicated that patients...

How Proteins in Acute Myeloid Leukemia Support Precision Medicine

by Erin McNemar, MPA

Sanford Burnham Prebys Medical Discovery Institute scientists discovered that the protein RNF5 plays an unusual role in acute myeloid leukemia (AML). By targeting the specific protein, researchers...

Why Genetic Testing Is Key to Advancing Precision Medicine

by Erin McNemar, MPA

Due to genetics, not every patient responds the same to medications. With genetic testing, providers can better determine the best treatment options for individuals, advancing precision...

Blood Samples, Predictive Analytics Determine COVID-19 Outcomes

by Erin McNemar, MPA

A new study of blood samples from nearly 200 COVID-19 patients reveals underlying metabolic changes that regulate how immune cells respond to the infection. These changes are associated with disease...

Using Predictive, Data Analytics to Expand Knowledge of Alzheimer’s

by Erin McNemar, MPA

Using predictive and data analytics, Brigham and Women’s Hospital researchers developed a resource to better understand the cognitive decline in individuals due to Alzheimer’s disease...

Machine Learning Tool Detects Genetic Syndromes in Children

by Erin McNemar, MPA

Children’s National Hospital researchers developed a machine learning tool that offers rapid genetic screening, potentially accelerating the diagnosis of genetic syndromes in children. The deep...

Improving Cancer Treatment, Patient Outcomes with Genomic Testing

by Erin McNemar, MPA

New York University (NYU) is using a new kind of genomic testing to improve cancer treatment and patient outcomes. Cancer has proven to be difficult to manage for patients and healthcare providers....

Determining Family Impact of Genome Sequencing on Newborns

by Erin McNemar, MPA

Genome sequencing can reveal an individual’s risk for specific health conditions throughout their life. While some advocate for testing on all newborns to address disease risks early in life,...

Addressing Cardiovascular Genetic Testing in Children

by Erin McNemar, MPA

According to a new statement from the American Heart Association, cardiovascular genetic testing in children presents challenges that require pre-and post-test counseling with a personalized approach...